Log in to save to my catalogue

Sumatriptan ameliorates renal injury induced by cisplatin in mice

Sumatriptan ameliorates renal injury induced by cisplatin in mice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_85138c3e29f74b8788e069483b5964d9

Sumatriptan ameliorates renal injury induced by cisplatin in mice

About this item

Full title

Sumatriptan ameliorates renal injury induced by cisplatin in mice

Publisher

Iran: Mashhad University of Medical Sciences

Journal title

Iranian journal of basic medical sciences, 2019-05, Vol.22 (5), p.563-567

Language

English

Formats

Publication information

Publisher

Iran: Mashhad University of Medical Sciences

More information

Scope and Contents

Contents

Cisplatin (Cis) is an anticancer compound, which is used for the treatment of various cancers. Sumatriptan (Suma) is a selective agonist of 5-hydroxytryptamine 1B/1D (5HT1B/1D) receptor, which is prescribed for the management of migraine. It is well-established that Suma has anti-inflammatory and antioxidant properties. We have explored the protecti...

Alternative Titles

Full title

Sumatriptan ameliorates renal injury induced by cisplatin in mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_85138c3e29f74b8788e069483b5964d9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_85138c3e29f74b8788e069483b5964d9

Other Identifiers

ISSN

2008-3866

E-ISSN

2008-3874

DOI

10.22038/ijbms.2019.33620.8020

How to access this item